NFCR Writer David Perry, Author at NFCR - Page 6 of 10

NFCR Writer David Perry

New Type of Lung Cancer Identified

A research team at Cold Spring Harbor Laboratory discovered a new kind of small-cell lung cancer (SCLC). While the general public may not consider this particularly good news, the identification paves the way for developing more specific and personalized medicine approaches to target this previously unnoticed form of the disease....

Read more

November Is Pancreatic Cancer Awareness Month

Even in the company of other vicious diseases, pancreatic cancer is particularly nasty: The one-year relative survival rate is 20% and the five-year rate is 7%. It ranks third in cancer-related deaths in the United States, and it is expected that over 55,000 Americans will be diagnosed this year alone.…...

Read more

Liquid Biopsy Advances: Capturing Metastatic Cancer Cells

A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientists supported by the National Foundation for Cancer Research since 2003, the business card-sized…...

Read more

Breast Exams: At Home or Clinic?

There is a grim reality to both cancer research and funding: Each, to an enormous degree, is directed at early detection, not when metastasis has already taken place. Like most diseases, cancer is, in fact, fairly curable at its earliest stages. However, once a tumor begins to spread, mortality rates…...

Read more

Protein Identified in Breast Cancer Metastasis

Researchers from the University of Liverpool have found an explanation for how breast cancer spreads to the lungs, which could potentially hold the key to preventing the progression of the disease. Led by Dr. Ainhoa Mielgo, the research team conducted a study to gain a better understanding of how breast…...

Read more

Artemisinin Therapies: Connecting the Dots

You wouldn’t think it, but the science cannot be denied: One of the newest and most promising drug candidates for cancer was actually developed all the way back in 1972. For malaria. “There were some hints in the literature, but we were totally ignorant,” admits Curt Civin, M.D., whose work…...

Read more

The Lucy Fund: Words of a Mother

Lucy Elicker Stanovick, an English professor, writer, wife and mother of two, received the news that she had Stage IV metastatic breast cancer in April 2008. Although active, health conscious and just 42 years old, she was faced suddenly with her mortality: Stage IV metastatic breast cancer cannot be cured,…...

Read more

Peter Vogt: The Game Changer

The term “game changer” didn’t come into English usage until 1993, and since then it has been driven into the ground from overuse. But when applied to Peter Vogt, Ph.D., it is more than just hyperbole or overzealous marketing. When you are talking about the person that identified src, the…...

Read more